![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 44, 34672-34680, November 3, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Institute for Immunology, University of Munich,
Munich 80336, Germany
The cell adhesion molecule melonoma cell adhesion
molecule (MCAM)/MUC18/CD146 is specifically up-regulated on tumors of
neuroectodermal origin and in animal models confers metastatic capacity
to human melanoma cells. To identify critical regions regulating MCAM
expression in melanomas, 1 kilobase of the MCAM 5' region was analyzed
for promoter activity and transcription factor binding in 1 glioma, 1 carcinoma, and 4 melanoma cell lines. The minimal MCAM promoter (
Identification of the Elements Regulating the Expression of
the Cell Adhesion Molecule MCAM/MUC18
LOSS OF AP-2 IS NOT REQUIRED FOR MCAM EXPRESSION IN MELANOMA
CELL LINES*
106/+22 base pair (bp)) consists of 4 Sp-1 sites, two AP-2 elements, one cAMP responsive element, and the initiator surrounding the transcriptional start site. Analysis of mutated constructs indicated that the cAMP-responsive element is a major transcriptional activator in the majority of cell lines. Site-directed mutagenesis revealed that,
in AP-2 expressing cells, the AP-2 site within the core promoter (
23
bp) has an inhibitory influence on MCAM expression while the AP-2 sites
at
131 and
302 bp are activating. Functional AP-2 was observed in
both MCAM positive and MCAM negative melanoma cell lines indicating
that expression of MCAM does not require loss of this transcription
factor. Furthermore, all MCAM constructs were strongly expressed in
MCAM negative as well as MCAM positive cells, indicating that the
expression of this gene is not controlled solely by the presence of
transactivating factors binding to the investigated region.
*
This work was supported by grants from the Deutsche
Krebshilfe, Mildred Scheel Stiftung, Bonn (W 137/94/Jo1), and Deutsche Forschungsgemeinschaft SFB 455/B3, Bonn.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Institute for
Immunology, Goethestrasse 31, Munich 80336, Germany. Tel.:
49-89-5996-660; Fax: 49-89-5160-2467; E-mail:
johnson@ifi.med.uni-muenchen.de.
This article has been cited by other articles:
![]() |
S. Yoshioka, H. Fujiwara, T. Higuchi, S. Yamada, M. Maeda, and S. Fujii Melanoma cell adhesion molecule (MCAM/CD146) is expressed on human luteinizing granulosa cells: enhancement of its expression by hCG, interleukin-1 and tumour necrosis factor-{alpha} Mol. Hum. Reprod., June 1, 2003; 9(6): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Higuchi, H. Fujiwara, H. Egawa, Y. Sato, S. Yoshioka, K. Tatsumi, K. Itoh, M. Maeda, J. Fujita, and S. Fujii Cyclic AMP enhances the expression of an extravillous trophoblast marker, melanoma cell adhesion molecule, in choriocarcinoma cell JEG3 and human chorionic villous explant cultures Mol. Hum. Reprod., June 1, 2003; 9(6): 359 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Poser, D. Dominguez, A. G. de Herreros, A. Varnai, R. Buettner, and A. K Bosserhoff Loss of E-cadherin Expression in Melanoma Cells Involves Up-regulation of the Transcriptional Repressor Snail J. Biol. Chem., June 29, 2001; 276(27): 24661 - 24666. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |